Related Experiment Video
Updated: Jan 30, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.4K
Structure Based Drug Design: Clinically Relevant HIV-1 Integrase Inhibitors
Maninder Kaur1, Ravindra K Rawal2, Goutam Rath1
1ISF College of Pharmacy, Moga-142001, Punjab, India.
Current Topics in Medicinal Chemistry
|January 20, 2019
Summary
This review details structural insights for inhibiting HIV-1 integrase, a key target for anti-HIV drugs. Understanding these features aids in designing new antiviral agents and overcoming drug resistance.
Area of Science:
- Biochemistry
- Virology
- Drug Discovery
Background:
- HIV-1 integrase, a polynucleotidyl transferase, facilitates viral DNA integration into host genomes.
- Integrase is a critical target for developing anti-HIV therapeutics.
- Several integrase inhibitors are in clinical trials, with some already FDA-approved.
Purpose of the Study:
- To review structural insights for HIV-1 integrase inhibition.
- To discuss structural features for overcoming HIV resistance.
- To guide the design of novel antiviral inhibitors.
Main Methods:
- Literature review of structural biology studies.
- Analysis of clinically relevant HIV-1 integrase inhibitors.
- Examination of structure-activity relationships for resistance.
Main Results:
- Key structural features for effective HIV-1 integrase inhibition identified.
- Structural basis for overcoming HIV resistance elucidated.
- Insights into the mechanism of action of approved integrase inhibitors.
Conclusions:
- Structural understanding is crucial for developing potent and resistance-evading HIV-1 integrase inhibitors.
- This review provides valuable information for ongoing antiviral drug design.
- Targeting HIV-1 integrase remains a promising strategy in HIV therapy.
Keywords:
Anti-HIV therapeuticsHIV resistanceHIV-1 integraseNovel antiviral inhibitorsPolynucleotidyl transferasesViral DNA.More Related Videos
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
217
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
217
01:28Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.5K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.5K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.5K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.1K
01:52Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K